Publicații
Views: 90914
Unique visitors: 17821
SARS-CoV-2, COVID-19
201
202
Zhang T., Wu Q., Zhang Z. Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak, Curr Biol. 2020 Apr 6;30(7):1346-1351.e2. , doi: 10.1016/j.cub.2020.03.022
203
Barlow, A., Landolf, K.M., Barlow, B., Yeung, S.Y.A., Heavner, J.J., Claassen, C.W. and Heavner, M.S. Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019, Pharmacotherapy. 2020. , doi: https://doi.org/10.1002/phar.2398
204
Christian JA Sigrist, Alan Bridge, Philippe Le Mercier. A potential role for integrins in host cell entry by SARS-CoV-2, Antiviral Research, Volume 177, 2020, 104759, ISSN 0166-3542., doi: https://doi.org/10.1016/j.antiviral.2020.104759
205
Butowt R, Bilinska K. SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection, ACS Chem Neurosci. 2020;acschemneuro.0c00172., doi: doi:10.1021/acschemneuro.0c00172
206
Liu, J., Cao, R., Xu, M. et al. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro, Cell Discov 6, 16 (2020)., doi: https://doi.org/10.1038/s41421-020-0156-0
207
Tu, Y.-F.; Chien, C.-S.; Yarmishyn, A.A.; Lin, Y.-Y.; Luo, Y.-H.; Lin, Y.-T.; Lai, W.-Y.; Yang, D.-M.; Chou, S.-J.; Yang, Y.-P.; Wang, M.-L.; Chiou, S.-H. A Review of SARS-CoV-2 and the Ongoing Clinical Trials, Int. J. Mol. Sci. 2020, 21, 2657., doi: https://doi.org/10.3390/ijms21072657
208
Zhou, Y., Hou, Y., Shen, J. et al. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2, Cell Discov 6, 14 (2020)., doi: https://doi.org/10.1038/s41421-020-0153-3
209
di Mauro Gabriella, Scavone Cristina, Rafaniello Concetta, Rossi Francesco, Capuano Annalisa. SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment, International Immunopharmacology, Volume 84, 2020, 106519, ISSN 1567-5769., doi: https://doi.org/10.1016/j.intimp.2020.106519
210
Amanat F, Krammer F. SARS-CoV-2 Vaccines: Status Report, Immunity. 2020;52(4):583–589., doi: 10.1016/j.immuni.2020.03.007
